Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Total Liabilities (2016 - 2025)

Amphastar Pharmaceuticals has reported Total Liabilities over the past 13 years, most recently at $840.5 million for Q4 2025.

  • Quarterly results put Total Liabilities at $840.5 million for Q4 2025, down 0.55% from a year ago — trailing twelve months through Dec 2025 was $840.5 million (down 0.55% YoY), and the annual figure for FY2025 was $840.5 million, down 0.55%.
  • Total Liabilities for Q4 2025 was $840.5 million at Amphastar Pharmaceuticals, down from $889.5 million in the prior quarter.
  • Over the last five years, Total Liabilities for AMPH hit a ceiling of $949.5 million in Q3 2023 and a floor of $194.8 million in Q1 2021.
  • Median Total Liabilities over the past 5 years was $783.6 million (2023), compared with a mean of $569.0 million.
  • Biggest five-year swings in Total Liabilities: soared 328.61% in 2023 and later dropped 13.9% in 2024.
  • Amphastar Pharmaceuticals' Total Liabilities stood at $226.0 million in 2021, then fell by 5.61% to $213.3 million in 2022, then soared by 309.46% to $873.5 million in 2023, then dropped by 3.24% to $845.2 million in 2024, then dropped by 0.55% to $840.5 million in 2025.
  • The last three reported values for Total Liabilities were $840.5 million (Q4 2025), $889.5 million (Q3 2025), and $857.9 million (Q2 2025) per Business Quant data.